HealthDay Reporter Read article
- FDA-OK’d Drug Offers Hope to Sickest MS Patients
- New Eczema Drug Gets FDA’s Blessing
- Smoking Slows Recovery From Drug Abuse
- Study Suggests Heartburn Meds-Superbug Infections Link
- DAPT Cessation Patterns Vary With Diabetes Status After PCI
- TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates
- ACP Issues Challenge to Cut Task Burden and Put Patients First
Dr. A. De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
John Kenyon, CNA.
One of the most dreaded side effects of certain chemotherapy agents is their effect on the heart. The paradox comes from the fact that these drugs, while only a handful, are among the few chemotherapy agents with a substantial survival benefit. In some cases their use is unavoidable.
Tamer M. Fouad, M.D..
Johnson and Johnson is extending the voluntary recall of certain lots of OTC products in the Americas, the United Arab Emirates (UAE), and Fiji. This includes Tylenol, Motrin and St. Joseph’s aspirin.
Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.